EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 43 filers reported holding EVELO BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $35,000 | -58.3% | 10,400 | -25.2% | 0.00% | – |
| Q4 2021 | $84,000 | -14.3% | 13,900 | 0.0% | 0.00% | – |
| Q3 2021 | $98,000 | -48.7% | 13,900 | 0.0% | 0.00% | – |
| Q2 2021 | $191,000 | +60.5% | 13,900 | +25.2% | 0.00% | – |
| Q1 2021 | $119,000 | -23.2% | 11,100 | -13.3% | 0.00% | – |
| Q4 2020 | $155,000 | +131.3% | 12,800 | 0.0% | 0.00% | – |
| Q3 2020 | $67,000 | -9.5% | 12,800 | -14.7% | 0.00% | – |
| Q2 2020 | $74,000 | +76.2% | 15,000 | +35.1% | 0.00% | – |
| Q1 2020 | $42,000 | 0.0% | 11,100 | +7.8% | 0.00% | – |
| Q4 2019 | $42,000 | -33.3% | 10,300 | 0.0% | 0.00% | – |
| Q3 2019 | $63,000 | -31.5% | 10,300 | 0.0% | 0.00% | – |
| Q2 2019 | $92,000 | +13.6% | 10,300 | +2.0% | 0.00% | – |
| Q1 2019 | $81,000 | – | 10,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 484,953 | $1,823,000 | 4.61% |
| Flagship Pioneering Inc. | 18,233,403 | $68,558,000 | 3.21% |
| HARBOURVEST PARTNERS LLC | 1,763,505 | $6,622,000 | 3.20% |
| Alphabet Inc. | 1,060,495 | $3,982,000 | 0.26% |
| Larson Financial Group LLC | 20,042 | $75,000 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,500 | $501,000 | 0.01% |
| CREDIT SUISSE AG/ | 1,500,117 | $5,633,000 | 0.01% |
| FMR LLC | 3,220,853 | $12,094,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 177,856 | $668,000 | 0.00% |
| Legal & General Group Plc | 1,522 | $6,000 | 0.00% |